The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng‐Hua Wang, Rui‐Hua Xu, Xiujuan Qu et al.|癌症：英文版|2023Cited by 412
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Lin Xie, Yanqiao Zhang et al.|Nature Medicine|2025Cited by 89
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Lin Xie, Yanqiao Zhang et al.|Nature Medicine|2025Cited by 2